Unlock the Potential of Regulatory T Cells in Cell Therapy Manufacturing

SHARE NOW
Watch this on-demand webinar to find out about isolating ultra- rare cell populations at high purity using the CGX10 Cell Isolation System with Sony.
Thursday, October 10, 2024 | 09:00 [PDT] | 12:00 [EDT] | 16:00 [BST]
WATCH ON DEMAND | MEET THE PANEL
Exclusive webinar from Phacilitate in partnership with Sony: Unlocking regulatory T cells in cell therapy manufacturing
Watch this on-demand webinar to find out about isolating ultra- rare cell populations at high purity using the CGX10 Cell Isolation System with Sony.
The isolation and expansion of rare and ultra-rare cell populations are important for advancing cell therapy manufacturing. For example, Foxp3-positive naïve regulatory T cells (nTregs) may account for <1% of cells in a sample containing 1 billion leukocytes, making it extremely challenging to isolate them with high purity.
In this webinar, we provide data on how the CGX10 Cell Isolation System can sort these ultra-rare nTregs directly from a leukopak. We also share data on how the CGX10 system can be utilized for isolation of positively transduced T cells expressing a green fluorescent protein (GFP) marker at >97% purity using Purity mode.
This webinar describes how the CGX10 Cell Isolation System can be used to perform the following clinical-grade cell sorting workflow processes:
• High throughput sterile isolation and expansion of Foxp3-positive nTregs from 1 billion human leukocytes from a single donor, bypassing any bead-based pre-enrichment steps
• Isolation of positively transduced T cells expressing a GFP marker at high purity
• Sorting of CD4+ and CD8+ T cells directly after an RBC lysis step, at a predefined proportion, using Custom Purity mode
Listen to all this and more in this exclusive webinar.
This webinar is brought to you in partnership with Sony.